2-3. December 2023 Prince of Wales Hospital Hong Kong
The International Academy of Cytology and the Hong Kong Division of the International Academy of Pathology organised “The Cytopathology Tutorial” on December 2nd and 3rd 2023
Many thanks to the enthusiastic and participants who so obviously appreciated the expert faculty. The tutorial was co-directed by Dr Fernando Schmitt and Dr Gary Tse, also with invited lectures by Dr Zubair Baloch, USA, Dr Ashish Chandra, UK and Donna Russell, M.Ed, CFIAC
The speakers, as lead authors within international cytology reporting systems such as Bethesda (thyroid), International (serous fluid), Milan (salivary gland), Paris (urine) and Yokohama (breast), WHO (lung and pancreatobiliary) will be sharing their world renown expertise on cytology and molecular pathology. The course included lectures, slide seminars and daily Q&A sessions.
Location:
Student Laboratory, 1/F Clinical Sciences Building
Prince of Wales Hospital, Shatin, NT.
Hong Kong
Local Organization: HKIAP Limited, Tel: +852-9853-6273 Fax: +852-2637-6274
Email: HKIAPsecretariat@gmail.com
Professor Fernando Schmitt is a Professor of Pathology at the Medical Faculty of University of Porto, Senior Researcher and Head of Molecular Pathology Unit at IPATIMUP, Director of RISE (Clinical and Transnational Research Network of the Medical Faculty), Past-President of the International Society of Breast Pathology and President of the International Academy of Cytology (IAC). He has authored over 500 papers in peer-reviewed journals, 33 book chapters, and is the editor of six books. Prof Schmitt is widely considered a world-leading expert in cytopathology and breast cancer. Fernando was a fellow at the Karolinska Medical Hospital, Stockholm, and was a Professor of Pathology at the University of São Paulo (USP), Brazil, and University of Toronto, Canada. He was also Director of the Department of Medicine at Laboratoire national de Santé, Luxembourg. His research work is on breast cancer, with emphasis on molecular markers, cell adhesion and invasion, therapeutic targets, and mechanisms of resistance. In the last years, his research work has been dedicated to the study of molecular markers on cytological material. Fernando serves as Editor in Chief of Pathobiology and Associate Editor of six major scientific journals and sits on the editorial board of many others. He is a standing member of the WHO-IAC Classification of Tumours. He has also been chair, president, or scientific director of several major European, Portuguese, and Brazilian scientific societies of pathology and cytology. He received the following prizes: Educator of the Year 2011 by the PSC, GOLDBLATT AWARD 2013 by the IAC, Dario Cruz 2018 from the Portuguese League Against Cancer for his career as a researcher in breast cancer, and the 2021 International Achievement Award from the American Society of Cytopathology.
Faculty
Dr. Zubair Baloch, MIAC
U.S.A.
Faculty
Dr. Zubair Baloch, MIAC
U.S.A.
Dr. Baloch received his medical degree from Liaquat Medical University in Sind, Pakistan. After receiving his PhD in 1991 he joined the pathology residency at Hahnemann University Hospital. This was followed by fellowships in surgical pathology at Memorial Sloan Kettering Cancer Center, New York and cytopathology at the University of Pennsylvania Medical Center, Philadelphia. Dr. Baloch began his career as an assistant professor in the Department of Pathology & Laboratory Medicine at UPENN medical center in1997 and is currently a professor of pathology and laboratory medicine there. He has authored more than 200 peer reviewed publications in leading pathology journals on the subject of endocrine and head and neck pathology; and book chapters and monographs. Dr. Baloch has delivered numerous lectures, workshops and short courses both at the national and international meetings including ASC, USCAP, ASCP, CAP, ECC and IAP. Dr. Baloch has co-authored 3 books and has served as co-editor of the most recent Milan System for Reporting Salivary Gland Cytopathology. Dr. Baloch has also served as the chair of the terminology and morphologic criteria committee of the 2007 NCI sponsored thyroid FNA initiative which led to the development of ?Bethesda Thyroid FNA Classification Scheme?. Dr. Baloch also served on the international panel which recommended the renaming of encapsulated follicular variant of papillary thyroid carcinoma to non-invasive follicular tumor with papillary like nuclear features (NIFTP). Dr. Baloch is executive editor of Diagnostic Cytopathology and member of the editorial board of Cancer Cytopathology, Cytojournal, Endocrine Pathology and Journal of American Society of Cytopathology.
Dr. Baloch has served as the chair of ASCP and ASC annual meeting scientific program committee, member of USCAP education committee, ASC executive board, ASCP committee for continuing professional development, Papanicolaou Society scientific program committee, American Association of Endocrinologist thyroid nodule guideline task force and American Thyroid Association laboratory test committee.
Board Member
Gary Tse, MIAC
Hong Kong
Board Member
Gary Tse, MIAC
Hong Kong
Prof Tse is a chairman and professor in the Department of Anatomical and Cellular Pathology, Prince of Wales Hospital and the Chinese University of Hong Kong. He is the president of the Hong Kong Division of International Academy of Pathology. He is currently the regional editor for Australasia, Histopathology, overseas editor for Journal of the American Society of Cytopathology, outreach editor for Cytopathology, associate editor for Pathology, associate editor for Breast Cancer Research and Treatment, editorial advisory board member for Cancer Cytopathology, advisory board member for eBioMedicine and editorial board member for other journals including Acta Cytologica, Chinese Pathology Journal, Diagnostic Cytopathology, Human Pathology Case Reports, Journal of Pathology and Translational Medicine, Modern Pathology and Seminars in Diagnostic Pathology. Prof Tse has given many invited presentations, convened regional and international meetings and has published actively in breast pathology, and has published extensively.
Faculty
Dr. Ashish Chandra, MIAC
United Kingdom
Faculty
Dr. Ashish Chandra, MIAC
United Kingdom
Dr Ashish Chandra MD FRCPath DipRCPath (Cytol), MIAC, Vice-President IAC, Guy’s and St. Thomas’ NHS Foundation Trust, London, United Kingdom. He is a co-editor of the International system for reporting serous fluid cytopathology and is a contributor to other terminology systems and clinical guidelines. His interests include FNA, ROSE and genito-urinary histopathology.
Faculty
Donna Russell, M.Ed, CFIAC
U.S.A.
Faculty
Donna Russell, M.Ed, CFIAC
U.S.A.
Donna Russell is a graduate of the State University of New York, Upstate Medical Center in Syracuse, NY and has been an employee at the University of Rochester Medical Center for over 35 years. She received her Master?s in Education from the University of Rochester Graduate School of Education and currently is the Education Coordinator of the Cytopathology Resident/Fellow Training program at the University of Rochester. She also is the Program Director of the Roswell Park Comprehensive Cancer Center/Daemen College School of Cytotechnology. She currently is educating the eighth class from this Master’s level program in cytology.
Donna is an active member of numerous cytology organizations. Her special interests are in gynecologic, cell block preparation, ROSE and telecytology. She has published book chapters and many manuscripts in all areas of cytology. Donna has played an active role in teaching within the IAC, ECC, ASC, ASCP, ASCT and CAP. She has presenting numerous workshops, panel luncheons, and teleconferences in diagnostic cytopathology and related topics.
